US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

22.61

+0.23001.03%

Volume:254.14K

Turnover:5.74M

Market Cap:1.99B

PE:-5.17

High:22.82

Open:22.49

Low:22.37

Close:22.38

52wk High:47.65

52wk Low:21.46

Shares:88.16M

Float Shares:66.03M

Volume Ratio:0.91

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.3763

EPS(LYR):-2.2900

ROE:-80.88%

ROA:-46.18%

PB:3.62

PE(LYR):-9.87

Loading ...

Overview Company News Filings

Mineralys Therapeutics - Prices $150 Mln Common Stock Offering

THOMSON REUTERS

Mineralys Therapeutics - to Repurchase Lorundrostat Royalty Obligation for $200 Mln Upfront, up to $100 Mln in Milestones

THOMSON REUTERS

Buy Rating Reiterated on MLYS as Launch-HTN Data Highlight Lorundrostat’s Efficacy in Resistant CKD Hypertension; $54 Price Target Unchanged

Mineralys publishes ESH 2026 presentation on lorundrostat in CKD hypertension trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

Mineralys Therapeutics presents new data for lorundrostat

BRIEF-Mineralys Therapeutics Presents New Data From The Phase 3 Launch-Htn Trial Of Lorundrostat

Mineralys Therapeutics Presents New Data From the Phase 3 Launch-Htn Trial of Lorundrostat in Participants With Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

THOMSON REUTERS

Mineralys Therapeutics: Lorundrostat Showed Significant Blood Pressure Reductions in Ckd Patients in Phase 3 Launch-Htn Trial

THOMSON REUTERS

Mineralys Therapeutics: Lorundrostat Significantly Reduced Urine Albumin-to-Creatinine Ratio in Trial

THOMSON REUTERS

Mineralys' pill cuts blood pressure in kidney disease patients

Mineralys Therapeutics: Lorundrostat Demonstrated Favorable Safety Profile in Participants With and Without Chronic Kidney Disease Over 12 Weeks

THOMSON REUTERS

Bayer's Key Pharma Products Face Competitive Risk -- Market Talk

Will Phase 3 Launch-HTN Success and Conference Spotlight Change Mineralys Therapeutics' (MLYS) Narrative?

Simply Wall St.

Mineralys Therapeutics to Present at Jefferies Global Healthcare Conference

Mineralys Therapeutics shareholders approve Ernst & Young as auditor

Mineralys CMO David Malcom Rodman disposes of 417 shares for $11,491.35

Guggenheim Keeps Their Buy Rating on Mineralys Therapeutics, Inc. (MLYS)

Mineralys presents Phase 3 Launch-HTN lorundrostat data in hypertension, CKD at ESH 2026

BRIEF-Mineralys Therapeutics Announces Presentation Of New Data From The Late-Stage Launch-Htn Trial Of Lorundrostat

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/MLYS/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MLYS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":22.61,"timestamp":1791557585192,"preClose":22.38,"halted":0,"volume":254144,"delay":0,"changeRate":0.010277033065236838,"floatShares":66025800,"shares":88158500,"eps":-4.37633,"marketStatus":"Trading","change":0.23,"latestTime":"10-09 10:53:24 EDT","open":22.49,"high":22.82,"low":22.365,"amount":5737579.595968001,"amplitude":0.020331,"askPrice":22.65,"askSize":145,"bidPrice":22.58,"bidSize":109,"shortable":3,"etf":0,"ttmEps":-4.37633,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":22.38,"preHourTrading":{"tag":"盘前","latestPrice":22.99,"preClose":22.38,"latestTime":"09:28 EDT","volume":456,"amount":10274.800392000001,"timestamp":1791552480025,"change":0.61,"changeRate":0.027256,"amplitude":0.055407},"postHourTrading":{"tag":"盘后","latestPrice":22.7,"preClose":22.38,"latestTime":"19:46 EDT","volume":40516,"amount":906823.8492,"timestamp":1791503204006,"change":0.32,"changeRate":0.014298,"amplitude":0.014298},"volumeRatio":0.913587,"impliedVol":0.816,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","floatShares":66025800,"roa":"-46.18%","roe":"-80.88%","lyrEps":-2.29,"volumeRatio":0.913587,"shares":88158500,"dividePrice":0,"high":22.82,"amplitude":0.020331,"preClose":22.38,"low":22.365,"week52Low":21.46,"pbRate":"3.62","week52High":47.65,"institutionHeld":0,"latestPrice":22.61,"committee":-0.141732,"eps":-4.37633,"divideRate":0,"volume":254144,"delay":0,"ttmEps":-4.37633,"open":22.49,"prevYearClose":36.29,"prevWeekClose":23.63,"prevMonthClose":25.13,"prevQuarterClose":25.13,"fiveDayClose":23.63,"twentyDayClose":28.2,"sixtyDayClose":27.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MLYS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MLYS","fiscalQuarterEnding":"2026/06","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-2.85},{"market":"US","date":"2026-05-06","symbol":"MLYS","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2026-03-12","symbol":"MLYS","fiscalQuarterEnding":"2025/12","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2025-11-10","symbol":"MLYS","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2025-08-12","symbol":"MLYS","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MLYS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MLYS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1777348800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MLYS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MLYS","date":"2026-10-08","current":-5.168714,"percent":0.724176,"low":-28.120261,"twenty":-16.321217,"median":-8.863447,"eighty":-5.026967,"high":-2.455206,"avg":-10.675477,"sd":5.906281,"marketCap":1952908089},"quantilePoints":[{"date":"2023-02-10","current":-25.898259,"twenty":-24.067223,"median":-21.320668,"eighty":-10.744265,"marketCap":720204681},{"date":"2023-02-17","current":-26.342543,"twenty":-26.413064,"median":-26.058397,"eighty":-23.151704,"marketCap":732559788},{"date":"2023-02-24","current":-26.298468,"twenty":-26.483585,"median":-26.320505,"eighty":-25.926348,"marketCap":731334088},{"date":"2023-03-03","current":-28.120261,"twenty":-26.483585,"median":-26.122165,"eighty":-25.407434,"marketCap":781996338},{"date":"2023-03-10","current":-23.918383,"twenty":-26.483585,"median":-26.166241,"eighty":-25.1907,"marketCap":665146310},{"date":"2023-03-17","current":-21.169392,"twenty":-26.45714,"median":-26.078089,"eighty":-23.824355,"marketCap":630826722},{"date":"2023-03-24","current":-20.744359,"twenty":-26.427757,"median":-25.591493,"eighty":-21.169392,"marketCap":618161159},{"date":"2023-03-31","current":-21.471029,"twenty":-26.354297,"median":-24.873355,"eighty":-21.103581,"marketCap":639815185},{"date":"2023-04-06","current":-19.11278,"twenty":-26.342543,"median":-23.918383,"eighty":-20.744359,"marketCap":569541742},{"date":"2023-04-14","current":-18.427243,"twenty":-26.298468,"median":-22.156566,"eighty":-20.113665,"marketCap":549113416},{"date":"2023-04-21","current":-18.879698,"twenty":-26.210316,"median":-21.471029,"eighty":-19.688632,"marketCap":562596111},{"date":"2023-04-28","current":-17.933656,"twenty":-26.122165,"median":-21.24503,"eighty":-18.783722,"marketCap":534405021},{"date":"2023-05-05","current":-20.086243,"twenty":-26.092781,"median":-21.087128,"eighty":-18.674036,"marketCap":598549966},{"date":"2023-05-12","current":-21.992037,"twenty":-26.078089,"median":-21.24503,"eighty":-18.728879,"marketCap":655340714},{"date":"2023-05-19","current":-21.745244,"twenty":-26.038705,"median":-21.457318,"eighty":-18.783722,"marketCap":647986516},{"date":"2023-05-26","current":-16.559387,"twenty":-25.898259,"median":-21.176247,"eighty":-18.591772,"marketCap":576895940},{"date":"2023-06-02","current":-16.969854,"twenty":-25.407434,"median":-21.12826,"eighty":-18.572577,"marketCap":591195768},{"date":"2023-06-09","current":-17.990156,"twenty":-25.1907,"median":-20.744359,"eighty":-18.397637,"marketCap":626741057},{"date":"2023-06-16","current":-18.271619,"twenty":-24.932123,"median":-20.360458,"eighty":-18.2552,"marketCap":636546653},{"date":"2023-06-23","current":-18.869727,"twenty":-24.820464,"median":-20.099954,"eighty":-18.341985,"marketCap":657383546},{"date":"2023-06-30","current":-19.432652,"twenty":-24.438476,"median":-19.960543,"eighty":-18.318529,"marketCap":676994740},{"date":"2023-07-07","current":-18.177798,"twenty":-23.894876,"median":-19.784607,"eighty":-18.295074,"marketCap":633278121},{"date":"2023-07-14","current":-18.224708,"twenty":-23.631036,"median":-19.510392,"eighty":-18.189525,"marketCap":634912387},{"date":"2023-07-21","current":-17.403775,"twenty":-22.844845,"median":-19.344695,"eighty":-18.039908,"marketCap":606312730},{"date":"2023-07-28","current":-16.395201,"twenty":-22.373196,"median":-18.879698,"eighty":-17.903799,"marketCap":571176008},{"date":"2023-08-04","current":-15.996462,"twenty":-22.189472,"median":-18.77395,"eighty":-17.722767,"marketCap":557284746},{"date":"2023-08-11","current":-13.235538,"twenty":-22.153824,"median":-18.728996,"eighty":-17.560925,"marketCap":536039287},{"date":"2023-08-18","current":-12.28726,"twenty":-22.129144,"median":-18.70554,"eighty":-17.406121,"marketCap":497634033},{"date":"2023-08-25","current":-13.043865,"twenty":-22.057849,"median":-18.632904,"eighty":-17.159841,"marketCap":528276523},{"date":"2023-09-01","current":-12.953072,"twenty":-21.986553,"median":-18.590018,"eighty":-16.81974,"marketCap":524599424},{"date":"2023-09-08","current":-11.823209,"twenty":-21.9701,"median":-18.578061,"eighty":-16.550005,"marketCap":478839973},{"date":"2023-09-15","current":-12.055235,"twenty":-21.909773,"median":-18.516678,"eighty":-16.005844,"marketCap":488237003},{"date":"2023-09-21","current":-10.249471,"twenty":-21.805571,"median":-18.455971,"eighty":-13.439317,"marketCap":415103594},{"date":"2023-09-29","current":-9.381898,"twenty":-21.588941,"median":-18.399822,"eighty":-13.144746,"marketCap":379966872},{"date":"2023-10-06","current":-9.926653,"twenty":-21.476513,"median":-18.254027,"eighty":-13.011583,"marketCap":402029465},{"date":"2023-10-13","current":-8.655558,"twenty":-21.471029,"median":-18.201253,"eighty":-12.658501,"marketCap":350550082},{"date":"2023-10-20","current":-8.221771,"twenty":-21.462802,"median":-18.183661,"eighty":-12.299366,"marketCap":332981721},{"date":"2023-10-27","current":-8.12089,"twenty":-21.457318,"median":-18.137991,"eighty":-12.28726,"marketCap":328896056},{"date":"2023-11-03","current":-7.868689,"twenty":-21.320668,"median":-17.990156,"eighty":-12.105675,"marketCap":318681893},{"date":"2023-11-10","current":-5.375877,"twenty":-21.183103,"median":-17.914995,"eighty":-11.823209,"marketCap":304177873},{"date":"2023-11-17","current":-4.874613,"twenty":-21.169392,"median":-17.861152,"eighty":-10.774051,"marketCap":275815341},{"date":"2023-11-24","current":-4.554966,"twenty":-21.169392,"median":-17.720421,"eighty":-10.138503,"marketCap":257729089},{"date":"2023-12-01","current":-4.838289,"twenty":-21.103581,"median":-17.57969,"eighty":-9.743051,"marketCap":273760085},{"date":"2023-12-08","current":-5.012642,"twenty":-21.06519,"median":-17.497596,"eighty":-9.458568,"marketCap":283625314},{"date":"2023-12-15","current":-5.993376,"twenty":-20.807428,"median":-17.409639,"eighty":-9.291106,"marketCap":339117223},{"date":"2023-12-22","current":-5.42673,"twenty":-20.459176,"median":-17.321682,"eighty":-8.792756,"marketCap":307055231},{"date":"2023-12-29","current":-6.225847,"twenty":-20.376911,"median":-17.198542,"eighty":-8.403356,"marketCap":352270861},{"date":"2024-01-05","current":-6.269435,"twenty":-20.360458,"median":-17.051947,"eighty":-8.171331,"marketCap":354737168},{"date":"2024-01-12","current":-6.552758,"twenty":-20.360458,"median":-16.876033,"eighty":-7.818248,"marketCap":370768164},{"date":"2024-01-19","current":-6.007906,"twenty":-20.163024,"median":-16.565251,"eighty":-6.745999,"marketCap":339939325},{"date":"2024-01-26","current":-7.729639,"twenty":-20.091727,"median":-16.395201,"eighty":-6.689335,"marketCap":437358455},{"date":"2024-02-02","current":-9.226167,"twenty":-20.060621,"median":-16.002326,"eighty":-6.745999,"marketCap":522034998},{"date":"2024-02-09","current":-10.192372,"twenty":-19.90434,"median":-13.48774,"eighty":-6.843346,"marketCap":576704805},{"date":"2024-02-16","current":-13.090301,"twenty":-19.80106,"median":-13.291023,"eighty":-7.190598,"marketCap":740675419},{"date":"2024-02-23","current":-13.68452,"twenty":-19.784607,"median":-13.356595,"eighty":-7.398369,"marketCap":774297534},{"date":"2024-03-01","current":-13.439842,"twenty":-19.727022,"median":-13.369934,"eighty":-7.593212,"marketCap":760453134},{"date":"2024-03-08","current":-12.216449,"twenty":-19.581688,"median":-13.356595,"eighty":-7.704554,"marketCap":691231132},{"date":"2024-03-15","current":-11.010534,"twenty":-19.485713,"median":-13.235538,"eighty":-7.770699,"marketCap":622998016},{"date":"2024-03-22","current":-9.036021,"twenty":-19.447295,"median":-13.106761,"eighty":-7.810178,"marketCap":649671871},{"date":"2024-03-28","current":-8.822029,"twenty":-19.362286,"median":-13.087259,"eighty":-7.838424,"marketCap":634286212},{"date":"2024-04-05","current":-8.704678,"twenty":-19.199155,"median":-13.043865,"eighty":-7.874093,"marketCap":625848914},{"date":"2024-04-12","current":-9.049827,"twenty":-19.019547,"median":-12.93794,"eighty":-7.899633,"marketCap":650664494},{"date":"2024-04-19","current":-7.42072,"twenty":-18.87571,"median":-12.8631,"eighty":-7.899633,"marketCap":533534959},{"date":"2024-04-26","current":-7.620907,"twenty":-18.835325,"median":-12.698294,"eighty":-7.82767,"marketCap":547927995},{"date":"2024-05-03","current":-9.036021,"twenty":-18.775904,"median":-12.579814,"eighty":-7.852557,"marketCap":649671871},{"date":"2024-05-10","current":-7.800135,"twenty":-18.750105,"median":-12.324461,"eighty":-7.852557,"marketCap":708236638},{"date":"2024-05-17","current":-7.190448,"twenty":-18.728996,"median":-12.28726,"eighty":-7.795318,"marketCap":652878301},{"date":"2024-05-24","current":-6.68739,"twenty":-18.728949,"median":-12.230329,"eighty":-7.639315,"marketCap":607201644},{"date":"2024-05-31","current":-6.982663,"twenty":-18.724211,"median":-12.17115,"eighty":-7.398356,"marketCap":634011855},{"date":"2024-06-07","current":-7.18498,"twenty":-18.70554,"median":-12.105675,"eighty":-7.206751,"marketCap":652381815},{"date":"2024-06-14","current":-6.878771,"twenty":-18.699239,"median":-12.004794,"eighty":-7.147798,"marketCap":624578633},{"date":"2024-06-21","current":-6.583498,"twenty":-18.674036,"median":-11.801366,"eighty":-7.108428,"marketCap":597768421},{"date":"2024-06-28","current":-6.397585,"twenty":-18.632904,"median":-11.587276,"eighty":-7.004535,"marketCap":580887918},{"date":"2024-07-05","current":-6.796751,"twenty":-18.599998,"median":-11.08918,"eighty":-6.90283,"marketCap":617131352},{"date":"2024-07-12","current":-7.917695,"twenty":-18.591772,"median":-11.014903,"eighty":-6.90283,"marketCap":718910859},{"date":"2024-07-19","current":-7.217788,"twenty":-18.588966,"median":-10.834579,"eighty":-6.932357,"marketCap":655360728},{"date":"2024-07-26","current":-7.354489,"twenty":-18.580102,"median":-10.505451,"eighty":-6.973914,"marketCap":667772863},{"date":"2024-08-02","current":-6.468669,"twenty":-18.558077,"median":-10.192372,"eighty":-6.88752,"marketCap":587342228},{"date":"2024-08-09","current":-6.025759,"twenty":-18.551128,"median":-10.024815,"eighty":-6.843776,"marketCap":547126910},{"date":"2024-08-16","current":-4.076332,"twenty":-18.496301,"median":-9.845949,"eighty":-6.771136,"marketCap":487818681},{"date":"2024-08-23","current":-4.824282,"twenty":-18.473334,"median":-9.694629,"eighty":-6.684109,"marketCap":577326696},{"date":"2024-08-30","current":-5.156705,"twenty":-18.446961,"median":-9.491619,"eighty":-6.64802,"marketCap":617108036},{"date":"2024-09-06","current":-4.666382,"twenty":-18.432727,"median":-9.462603,"eighty":-6.602089,"marketCap":558430560},{"date":"2024-09-13","current":-4.886612,"twenty":-18.41079,"median":-9.366766,"eighty":-6.532417,"marketCap":584785698},{"date":"2024-09-20","current":-4.865835,"twenty":-18.393266,"median":-9.226167,"eighty":-6.400866,"marketCap":582299364},{"date":"2024-09-27","current":-4.944786,"twenty":-18.318529,"median":-9.18084,"eighty":-6.305758,"marketCap":591747432},{"date":"2024-10-04","current":-5.767531,"twenty":-18.250509,"median":-9.070536,"eighty":-6.252,"marketCap":690206249},{"date":"2024-10-11","current":-5.634562,"twenty":-18.229399,"median":-9.042924,"eighty":-6.143869,"marketCap":674293713},{"date":"2024-10-18","current":-5.983606,"twenty":-18.210635,"median":-8.998552,"eighty":-6.048725,"marketCap":716064120},{"date":"2024-10-25","current":-5.655339,"twenty":-18.194216,"median":-8.973895,"eighty":-5.961361,"marketCap":676780046},{"date":"2024-11-01","current":-5.588854,"twenty":-18.189525,"median":-8.92105,"eighty":-5.849535,"marketCap":668823778},{"date":"2024-11-08","current":-5.834016,"twenty":-18.182489,"median":-8.908316,"eighty":-5.825113,"marketCap":698162517},{"date":"2024-11-15","current":-3.728112,"twenty":-18.13003,"median":-8.863447,"eighty":-5.784153,"marketCap":571344320},{"date":"2024-11-22","current":-4.056108,"twenty":-18.054477,"median":-8.834854,"eighty":-5.738445,"marketCap":621610675},{"date":"2024-11-29","current":-4.147037,"twenty":-18.011266,"median":-8.824542,"eighty":-5.694398,"marketCap":635545903},{"date":"2024-12-06","current":-4.289927,"twenty":-17.971392,"median":-8.704678,"eighty":-5.652845,"marketCap":657444117},{"date":"2024-12-13","current":-3.864506,"twenty":-17.93941,"median":-8.597282,"eighty":-5.622096,"marketCap":592247161},{"date":"2024-12-20","current":-4.007395,"twenty":-17.918728,"median":-8.45617,"eighty":-5.566415,"marketCap":614145375},{"date":"2024-12-27","current":-4.163275,"twenty":-17.89399,"median":-8.38318,"eighty":-5.386048,"marketCap":638034336},{"date":"2025-01-03","current":-4.140542,"twenty":-17.884608,"median":-8.283595,"eighty":-5.230583,"marketCap":634550529},{"date":"2025-01-10","current":-3.205267,"twenty":-17.865843,"median":-8.193856,"eighty":-5.186749,"marketCap":491216763},{"date":"2025-01-17","current":-3.000675,"twenty":-17.75795,"median":-8.130978,"eighty":-5.093743,"marketCap":459862501},{"date":"2025-01-24","current":-3.237742,"twenty":-17.725112,"median":-7.972375,"eighty":-5.030384,"marketCap":496193629},{"date":"2025-01-31","current":-3.344909,"twenty":-17.66738,"median":-7.925786,"eighty":-4.98717,"marketCap":512617290},{"date":"2025-02-07","current":-3.185782,"twenty":-17.600622,"median":-7.886161,"eighty":-4.961636,"marketCap":488230642},{"date":"2025-02-14","current":-2.870012,"twenty":-17.57969,"median":-7.841803,"eighty":-4.929578,"marketCap":510316922},{"date":"2025-02-21","current":-2.679426,"twenty":-17.570308,"median":-7.800135,"eighty":-4.913205,"marketCap":476428689},{"date":"2025-02-28","current":-2.56171,"twenty":-17.532779,"median":-7.76156,"eighty":-4.879413,"marketCap":455497722},{"date":"2025-03-07","current":-2.948489,"twenty":-17.497596,"median":-7.666927,"eighty":-4.847705,"marketCap":524270901},{"date":"2025-03-14","current":-5.032788,"twenty":-17.464759,"median":-7.556805,"eighty":-4.833314,"marketCap":894880035},{"date":"2025-03-21","current":-6.142597,"twenty":-17.410812,"median":-7.474785,"eighty":-4.837364,"marketCap":1092215135},{"date":"2025-03-28","current":-5.337906,"twenty":-17.394393,"median":-7.420413,"eighty":-4.839437,"marketCap":949133010},{"date":"2025-04-04","current":-4.515009,"twenty":-17.356865,"median":-7.381829,"eighty":-4.839437,"marketCap":802813733},{"date":"2025-04-11","current":-4.88916,"twenty":-17.298227,"median":-7.359957,"eighty":-4.826979,"marketCap":869341455},{"date":"2025-04-17","current":-4.870916,"twenty":-17.237243,"median":-7.346287,"eighty":-4.83217,"marketCap":866097643},{"date":"2025-04-25","current":-4.867268,"twenty":-17.117621,"median":-7.217788,"eighty":-4.83083,"marketCap":865448881},{"date":"2025-05-02","current":-5.626182,"twenty":-17.049602,"median":-7.174044,"eighty":-4.83217,"marketCap":1000391435},{"date":"2025-05-09","current":-5.345238,"twenty":-17.026147,"median":-7.146704,"eighty":-4.837056,"marketCap":950436740},{"date":"2025-05-16","current":-5.307011,"twenty":-16.932326,"median":-7.108428,"eighty":-4.838863,"marketCap":1000440655},{"date":"2025-05-23","current":-5.642373,"twenty":-16.739993,"median":-7.070152,"eighty":-4.844431,"marketCap":1063660683},{"date":"2025-05-30","current":-5.414189,"twenty":-16.571115,"median":-7.048279,"eighty":-4.857525,"marketCap":1020644994},{"date":"2025-06-06","current":-5.40036,"twenty":-16.559387,"median":-6.993599,"eighty":-4.86168,"marketCap":1018037982},{"date":"2025-06-13","current":-5.158346,"twenty":-16.512477,"median":-6.906111,"eighty":-4.865835,"marketCap":972415282},{"date":"2025-06-20","current":-4.746923,"twenty":-16.418656,"median":-6.878771,"eighty":-4.854252,"marketCap":894856690},{"date":"2025-06-27","current":-4.840271,"twenty":-16.273234,"median":-6.854165,"eighty":-4.839875,"marketCap":912454018},{"date":"2025-07-03","current":-5.026967,"twenty":-16.102011,"median":-6.815889,"eighty":-4.834459,"marketCap":947648672},{"date":"2025-07-11","current":-5.061541,"twenty":-16.001153,"median":-6.774878,"eighty":-4.830927,"marketCap":954166201},{"date":"2025-07-18","current":-4.95782,"twenty":-15.757219,"median":-6.718225,"eighty":-4.834459,"marketCap":934613615},{"date":"2025-07-25","current":-4.930162,"twenty":-14.706714,"median":-6.670986,"eighty":-4.828181,"marketCap":929399592},{"date":"2025-08-01","current":-4.892131,"twenty":-14.028818,"median":-6.651848,"eighty":-4.823763,"marketCap":922230311},{"date":"2025-08-08","current":-4.449592,"twenty":-13.915218,"median":-6.625405,"eighty":-4.809096,"marketCap":838805943},{"date":"2025-08-15","current":-4.827344,"twenty":-13.761419,"median":-6.586232,"eighty":-4.762827,"marketCap":920926805},{"date":"2025-08-22","current":-5.077095,"twenty":-13.590144,"median":-6.552758,"eighty":-4.766426,"marketCap":968572638},{"date":"2025-08-29","current":-5.289075,"twenty":-13.503535,"median":-6.457733,"eighty":-4.786431,"marketCap":1009012700},{"date":"2025-09-05","current":-13.211526,"twenty":-13.468581,"median":-6.485287,"eighty":-4.805659,"marketCap":2520402357},{"date":"2025-09-12","current":-15.109527,"twenty":-13.879712,"median":-6.581817,"eighty":-4.817518,"marketCap":2882489791},{"date":"2025-09-19","current":-16.211433,"twenty":-14.67771,"median":-6.599902,"eighty":-4.819952,"marketCap":3092703659},{"date":"2025-09-26","current":-15.658447,"twenty":-15.194101,"median":-6.643646,"eighty":-4.82127,"marketCap":2987208877},{"date":"2025-10-03","current":-16.451331,"twenty":-15.631718,"median":-6.654582,"eighty":-4.823503,"marketCap":3138469778},{"date":"2025-10-10","current":-16.016261,"twenty":-15.631718,"median":-6.68739,"eighty":-4.825507,"marketCap":3055470207},{"date":"2025-10-17","current":-17.471915,"twenty":-15.790187,"median":-6.743652,"eighty":-4.828719,"marketCap":3333169708},{"date":"2025-10-24","current":-16.593644,"twenty":-16.004913,"median":-6.791282,"eighty":-4.830879,"marketCap":3165619171},{"date":"2025-10-31","current":-16.719692,"twenty":-16.218752,"median":-6.840495,"eighty":-4.833314,"marketCap":3189665776},{"date":"2025-11-07","current":-15.048536,"twenty":-16.218752,"median":-6.86514,"eighty":-4.837364,"marketCap":2870854337},{"date":"2025-11-14","current":-20.454291,"twenty":-16.296821,"median":-6.897909,"eighty":-4.839082,"marketCap":3505108651},{"date":"2025-11-21","current":-19.336671,"twenty":-16.504283,"median":-6.982663,"eighty":-4.840626,"marketCap":3313589957},{"date":"2025-11-28","current":-19.913954,"twenty":-16.568769,"median":-7.015471,"eighty":-4.844431,"marketCap":3412514902},{"date":"2025-12-05","current":-17.969665,"twenty":-16.769708,"median":-7.064684,"eighty":-4.858356,"marketCap":3079335687},{"date":"2025-12-12","current":-16.648841,"twenty":-16.96846,"median":-7.108428,"eighty":-4.862511,"marketCap":2852995413},{"date":"2025-12-19","current":-17.087577,"twenty":-17.041159,"median":-7.14397,"eighty":-4.866122,"marketCap":2928178372},{"date":"2025-12-26","current":-17.286162,"twenty":-17.087577,"median":-7.15764,"eighty":-4.867268,"marketCap":2962208553},{"date":"2026-01-02","current":-16.75968,"twenty":-17.088816,"median":-7.187714,"eighty":-4.870186,"marketCap":2871989003},{"date":"2026-01-09","current":-15.300308,"twenty":-17.059073,"median":-7.271963,"eighty":-4.873874,"marketCap":2621906742},{"date":"2026-01-16","current":-14.492112,"twenty":-17.043505,"median":-7.354489,"eighty":-4.884212,"marketCap":2483411819},{"date":"2026-01-23","current":-15.831409,"twenty":-17.04069,"median":-7.370893,"eighty":-4.887849,"marketCap":2712917691},{"date":"2026-01-30","current":-14.820009,"twenty":-17.021528,"median":-7.392765,"eighty":-4.888966,"marketCap":2539601188},{"date":"2026-02-06","current":-13.028123,"twenty":-17.009066,"median":-7.434083,"eighty":-4.890943,"marketCap":2232538158},{"date":"2026-02-13","current":-12.866483,"twenty":-16.985539,"median":-7.48264,"eighty":-4.894697,"marketCap":2204839174},{"date":"2026-02-20","current":-12.958849,"twenty":-16.967066,"median":-7.595082,"eighty":-4.899313,"marketCap":2220667165},{"date":"2026-02-27","current":-13.40682,"twenty":-16.890615,"median":-7.678432,"eighty":-4.90682,"marketCap":2297432922},{"date":"2026-03-06","current":-12.340001,"twenty":-16.773199,"median":-7.793482,"eighty":-4.913205,"marketCap":2114619624},{"date":"2026-03-13","current":-12.464694,"twenty":-16.743685,"median":-7.809191,"eighty":-4.917335,"marketCap":2135987412},{"date":"2026-03-20","current":-12.403799,"twenty":-16.719061,"median":-7.868689,"eighty":-4.919816,"marketCap":1918259847},{"date":"2026-03-27","current":-12.579626,"twenty":-16.690405,"median":-7.90391,"eighty":-4.921211,"marketCap":1945451675},{"date":"2026-04-02","current":-14.071491,"twenty":-16.647917,"median":-7.936683,"eighty":-4.923691,"marketCap":2176170213},{"date":"2026-04-10","current":-14.476426,"twenty":-16.642376,"median":-7.972375,"eighty":-4.925502,"marketCap":2238793817},{"date":"2026-04-17","current":-16.293018,"twenty":-16.630784,"median":-8.156199,"eighty":-4.925808,"marketCap":2519731592},{"date":"2026-04-24","current":-15.189401,"twenty":-16.609908,"median":-8.221771,"eighty":-4.927198,"marketCap":2349056055},{"date":"2026-05-01","current":-14.208408,"twenty":-16.589138,"median":-8.357548,"eighty":-4.930594,"marketCap":2197344467},{"date":"2026-05-08","current":-15.944002,"twenty":-16.568769,"median":-8.45617,"eighty":-4.933174,"marketCap":2419964732},{"date":"2026-05-15","current":-14.822362,"twenty":-16.554853,"median":-8.597282,"eighty":-4.937273,"marketCap":2249723214},{"date":"2026-05-22","current":-16.431243,"twenty":-16.531871,"median":-8.704678,"eighty":-4.940953,"marketCap":2493917593},{"date":"2026-05-29","current":-17.143281,"twenty":-16.536719,"median":-8.822029,"eighty":-4.944786,"marketCap":2601990105},{"date":"2026-06-05","current":-13.615701,"twenty":-16.559387,"median":-8.834854,"eighty":-4.947538,"marketCap":2066577430},{"date":"2026-06-12","current":-13.01237,"twenty":-16.536719,"median":-8.863447,"eighty":-4.950906,"marketCap":1975004537},{"date":"2026-06-18","current":-13.659184,"twenty":-16.517325,"median":-8.904865,"eighty":-4.950906,"marketCap":2073177278},{"date":"2026-06-26","current":-14.316868,"twenty":-16.496089,"median":-8.91986,"eighty":-4.950906,"marketCap":2172999980},{"date":"2026-07-02","current":-15.61864,"twenty":-16.491889,"median":-8.953186,"eighty":-4.955054,"marketCap":2370581500},{"date":"2026-07-10","current":-16.820967,"twenty":-16.545786,"median":-8.994603,"eighty":-4.959972,"marketCap":2553069551},{"date":"2026-07-17","current":-15.728998,"twenty":-16.522174,"median":-9.036021,"eighty":-4.961636,"marketCap":2387331611},{"date":"2026-07-24","current":-15.682531,"twenty":-16.500186,"median":-9.059079,"eighty":-4.964053,"marketCap":2380278933},{"date":"2026-07-31","current":-15.212055,"twenty":-16.491923,"median":-9.139785,"eighty":-4.966614,"marketCap":2308870565},{"date":"2026-08-07","current":-15.676723,"twenty":-16.49182,"median":-9.209355,"eighty":-4.972127,"marketCap":2379397348},{"date":"2026-08-14","current":-6.598095,"twenty":-16.488725,"median":-9.208309,"eighty":-4.97969,"marketCap":2306535629},{"date":"2026-08-21","current":-6.51211,"twenty":-16.477941,"median":-9.105161,"eighty":-4.985507,"marketCap":2276477288},{"date":"2026-08-28","current":-6.577863,"twenty":-16.46177,"median":-9.049827,"eighty":-4.997142,"marketCap":2299463078},{"date":"2026-09-04","current":-7.149411,"twenty":-16.443296,"median":-9.017287,"eighty":-5.008141,"marketCap":2499262638},{"date":"2026-09-11","current":-7.409896,"twenty":-16.424035,"median":-8.9877,"eighty":-5.009681,"marketCap":2590321730},{"date":"2026-09-18","current":-7.076071,"twenty":-16.395128,"median":-8.93938,"eighty":-5.010273,"marketCap":2473624642},{"date":"2026-09-25","current":-6.724544,"twenty":-16.380982,"median":-8.915219,"eighty":-5.014552,"marketCap":2350739072},{"date":"2026-10-02","current":-5.998728,"twenty":-16.324694,"median":-8.863447,"eighty":-5.023148,"marketCap":2097011312},{"date":"2026-10-08","current":-5.586505,"twenty":-16.321217,"median":-8.863447,"eighty":-5.026967,"marketCap":1952908089}],"updateTime":1791557598285},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MLYS\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640033479","title":"Mineralys Therapeutics - Prices $150 Mln Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640033479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640033479?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640033239","title":"Mineralys Therapeutics - to Repurchase Lorundrostat Royalty Obligation for $200 Mln Upfront, up to $100 Mln in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2640033239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640033239?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640690049","title":"Buy Rating Reiterated on MLYS as Launch-HTN Data Highlight Lorundrostat’s Efficacy in Resistant CKD Hypertension; $54 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2640690049","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640690049?lang=en_us&edition=fundamental","pubTime":"2026-06-02 02:45","pubTimestamp":1780339524,"startTime":"0","endTime":"0","summary":"In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Mineralys Therapeutics, Inc., with a price target of $54....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-mlys-as-launch-htn-data-highlight-lorundrostats-efficacy-in-resistant-ckd-hypertension-54-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-mlys-as-launch-htn-data-highlight-lorundrostats-efficacy-in-resistant-ckd-hypertension-54-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640501199","title":"Mineralys publishes ESH 2026 presentation on lorundrostat in CKD hypertension trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640501199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640501199?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:35","pubTimestamp":1780324510,"startTime":"0","endTime":"0","summary":"Mineralys published an ESH 2026 presentation on lorundrostat for hypertension in chronic kidney disease, reporting results from the LAUNCH-HTN trial.Primary endpoint: ambulatory office systolic blood pressure fell 16.9 mmHg at 6 weeks on lorundrostat 50 mg; placebo-adjusted decline was 9.1 mmHg.Predefined 12-week endpoint: ambulatory office systolic blood pressure fell 19.0 mmHg; placebo-adjusted decline was 11.6 mmHg.CKD subgroup analysis included 192 participants with baseline eGFR under 60 mL/min/1.73m or UACR at least 30 mg/g, out of 800 with baseline renal data.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief on May 30, 2026, and is solely r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL3LP8vt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640953797","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640953797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640953797?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:40","pubTimestamp":1780310417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS), Iovance Biother...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-196?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-196?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986644","title":"Mineralys Therapeutics presents new data for lorundrostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986644","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640986644?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:05","pubTimestamp":1780261504,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) presented new clinical data for lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protecti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-presents-new-data-for-lorundrostat-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-presents-new-data-for-lorundrostat-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4007","EPV","MLYS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639360972","title":"BRIEF-Mineralys Therapeutics Presents New Data From The Phase 3 Launch-Htn Trial Of Lorundrostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2639360972","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639360972?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154139,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Presents New Data From The Phase 3 Launch-Htn Trial Of Lorundrostat May 30 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS PRESENTS NEW DATA FROM THE ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA7YXNFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639717609","title":"Mineralys Therapeutics Presents New Data From the Phase 3 Launch-Htn Trial of Lorundrostat in Participants With Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639717609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639717609?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA7YXNFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609748","title":"Mineralys Therapeutics: Lorundrostat Showed Significant Blood Pressure Reductions in Ckd Patients in Phase 3 Launch-Htn Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609748?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nP8N3Z60BO:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609712","title":"Mineralys Therapeutics: Lorundrostat Significantly Reduced Urine Albumin-to-Creatinine Ratio in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609712?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nP8N3Z60BO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639560974","title":"Mineralys' pill cuts blood pressure in kidney disease patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2639560974","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639560974?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":"Mineralys' pill cuts blood pressure in kidney disease patients  May 30 (Reuters) - Mineralys Therapeutics' MLYS.O experimental drug significantly reduced blood pressure in patients with chronic kidney","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nL4N4251J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0661504455.SGD","LU1267930813.SGD","LU2125909247.SGD","LU2468319806.SGD","LU1273509221.SGD","AZN.UK","LU2324357040.USD","IE00B3T34201.USD","LU1051770623.HKD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU1153585028.USD","LU0969580561.USD","LU0997586432.USD","LU0997586515.USD","LU0114720955.EUR","LU1003076772.USD","LU0640478417.SGD","LU1267930573.SGD","LU1153584641.USD","LU2539964713.USD","LU1023059063.AUD","MLYS","03165","LU0266013472.USD","LU0128525689.USD","LU2112291526.USD","LU0784384876.USD","LU0052756011.USD","LU1481600234.SGD","LU2433249047.HKD","LU2355687059.USD","LU0557290698.USD","LU0976567544.SGD","LU1261432733.SGD","LU0553294199.USD","LU0920840948.USD","LU0960981461.USD","LU1267930227.SGD","LU1355424745.HKD","LU0857590862.USD","LU1046234339.USD","LU0432979614.USD","IE00BFTCPJ56.SGD","LU2237443549.SGD","LU0289739699.SGD","LU0738911758.USD","LU1019632923.USD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639060971","title":"Mineralys Therapeutics: Lorundrostat Demonstrated Favorable Safety Profile in Participants With and Without Chronic Kidney Disease Over 12 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2639060971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639060971?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nP8N3Z60BO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639986640","title":"Bayer's Key Pharma Products Face Competitive Risk -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2639986640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639986640?lang=en_us&edition=fundamental","pubTime":"2026-05-29 16:15","pubTimestamp":1780042500,"startTime":"0","endTime":"0","summary":"0815 GMT - Bayer's pharmaceutical business has good momentum but faces risks over the medium term from potential competition to key products like its Kerendia kidney drug and asundexian for stroke prevention, Jefferies analysts say. The German group's pharma division should deliver annual sales growth of 2% over the 2025-2030 period, compared with the average growth rate of 5% among peers, according to Jefferies. Asundexian's potential market is a lot smaller after a trial for a type of heart arrhythmia known as atrial fibrillation failed and Bristol Myers Squibb's rival treatment milvexian could have an edge, they add. For Bayer's Kerendia, momentum is good for now, but the threat of competition looms on the horizon with AstraZeneca and Mineralys Therapeutics developing a new class of drugs, Jefferies says. Bayer shares fall 1.3%. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU0058720904.USD","LU1323610961.USD","BMY","LU0456855351.SGD","LU2125154935.USD","LU0061475181.USD","LU1291159041.SGD","LU0889565916.HKD","LU1989771016.USD","BAYRY","IE0002141913.USD","BK4007","IE00BJJMRZ35.SGD","LU1718418525.SGD","AZNH","LU1670710588.SGD","LU2456880835.USD","LU2125154778.USD","AZN","LU2360032135.SGD","LU1074936037.SGD","LU1670711123.USD","LU2237443382.USD","BK4139","LU2462157665.USD","LU0289739699.SGD","MLYS","LU1670710661.SGD","BK4532","LU0225284248.USD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU2237443895.HKD","IE00BFXG1179.USD","BK4568","LU0225771236.USD","LU1585245621.USD","LU1829250122.USD","LU0306806265.USD","LU1571399168.USD","LU1868836757.USD","LU0432979614.USD","LU1430594728.SGD","LU1868837300.USD","LU0882574055.USD","LU2237443622.USD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639496716","title":"Will Phase 3 Launch-HTN Success and Conference Spotlight Change Mineralys Therapeutics' (MLYS) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2639496716","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639496716?lang=en_us&edition=fundamental","pubTime":"2026-05-29 12:33","pubTimestamp":1780029238,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics recently highlighted that positive Phase 3 Launch-HTN data for lorundrostat in uncontrolled hypertension and chronic kidney disease were featured in an oral presentation at the European Meeting on Hypertension and Cardiovascular Protection 2026, following completion of six late-stage trials supporting its efficacy and safety profile.\nThe company also confirmed participation in the Jefferies 2026 Global Healthcare Conference, underscoring growing clinical and investor...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/will-phase-3-launch-htn-success-and-conference-spotlight-cha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/will-phase-3-launch-htn-success-and-conference-spotlight-cha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638128507","title":"Mineralys Therapeutics to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638128507","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638128507?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:00","pubTimestamp":1779883243,"startTime":"0","endTime":"0","summary":"Mineralys will present at the Jefferies 2026 Global Healthcare Conference in New York on June 3, 2026 at 7:35 a.m. EDT.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief on May 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLrYD4M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637344056","title":"Mineralys Therapeutics shareholders approve Ernst & Young as auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2637344056","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637344056?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:50","pubTimestamp":1779483042,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics held its annual stockholder meeting on May 21, 2026.Stockholders backed the selection of three directors to serve as Class III directors with terms running to the 2029 annual meeting.The votes reflect stockholder authorization of these actions, not confirmation that any subsequent steps have been executed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL517xfy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636804898","title":"Mineralys CMO David Malcom Rodman disposes of 417 shares for $11,491.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2636804898","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636804898?lang=en_us&edition=fundamental","pubTime":"2026-05-20 07:15","pubTimestamp":1779232541,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Chief Medical Officer David Malcom Rodman sold 417 shares of common stock on May 18 at USD 27.55.The sale followed the exercise of a stock option for 417 shares at USD 15.44 on the same day.He ended the transactions with 63,443 shares of common stock.Rodman also reported 4,167 stock options beneficially owned following the transaction, with an exercise price of USD 15.44.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained ther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL5nVxrh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys CMO David Malcom Rodman disposes of 417 shares for $11,491.35","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636551788","title":"Guggenheim Keeps Their Buy Rating on Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636551788","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636551788?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:48","pubTimestamp":1779191338,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Seamus Fernandez maintained a Buy rating on Mineralys Therapeutics, Inc. yesterday and set a price target of $48.00. The company...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636006229","title":"Mineralys presents Phase 3 Launch-HTN lorundrostat data in hypertension, CKD at ESH 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636006229","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636006229?lang=en_us&edition=fundamental","pubTime":"2026-05-19 04:06","pubTimestamp":1779134819,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics flagged new Phase 3 LAUNCH-HTN trial data on lorundrostat in patients with uncontrolled hypertension and chronic kidney disease, scheduled for presentation at ESH 2026 on May 30.The oral presentation is set to highlight the drug’s efficacy profile in that population, alongside an update on tolerability and overall safety.The readout targets a high-risk subgroup that could broaden the commercial opportunity for an oral aldosterone-focused therapy in hypertension with kidney disease comorbidity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL5t3nqQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4585","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BKPKM429.USD","BK4112","BK4588","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","MLYS","IE00B64PRP62.GBP","SG9999014039.USD","LU2095319765.USD","BK4139","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636006279","title":"BRIEF-Mineralys Therapeutics Announces Presentation Of New Data From The Late-Stage Launch-Htn Trial Of Lorundrostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2636006279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636006279?lang=en_us&edition=fundamental","pubTime":"2026-05-19 04:06","pubTimestamp":1779134804,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Announces Presentation Of New Data From The Late-Stage Launch-Htn Trial Of Lorundrostat May 18 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS ANNOUNC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nTUA3BXNDC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":98,"code":"91000000","status":"200"}]}}